ATE273014T1 - VERWENDUNG DER BIOAKTIVEN FRAKTION AUS DEM URINDESTILLAT DER KUH (ßGO MUTRAß) ZUR VERSTÄRKUNG DER WIRKSAMKEIT VON ANTI-INFEKTIVA, ANTI-KREBSMITTELN UND ERNÄHRUNGSMITTELN - Google Patents

VERWENDUNG DER BIOAKTIVEN FRAKTION AUS DEM URINDESTILLAT DER KUH (ßGO MUTRAß) ZUR VERSTÄRKUNG DER WIRKSAMKEIT VON ANTI-INFEKTIVA, ANTI-KREBSMITTELN UND ERNÄHRUNGSMITTELN

Info

Publication number
ATE273014T1
ATE273014T1 AT00990873T AT00990873T ATE273014T1 AT E273014 T1 ATE273014 T1 AT E273014T1 AT 00990873 T AT00990873 T AT 00990873T AT 00990873 T AT00990873 T AT 00990873T AT E273014 T1 ATE273014 T1 AT E273014T1
Authority
AT
Austria
Prior art keywords
ßgo
mutraß
infectives
cow
cancer
Prior art date
Application number
AT00990873T
Other languages
English (en)
Inventor
Suman Preet Singh Khanuja
Sushil Kumar
Ajit Kumar Shasany
Jai Shankar Arya
Mahendra Pandurang Darokar
Monika Singh
Prachi Sinha
Soumya Awasthi
Subhash Chandra Gupta
Vivek Kumar Gupta
Madan Mohan Gupta
Ram Kishore Verma
Sweta Agarwal
Sunil Balkrishna Mansinghka
Suresh Haribhau Dawle
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Application granted granted Critical
Publication of ATE273014T1 publication Critical patent/ATE273014T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT00990873T 2000-10-20 2000-10-20 VERWENDUNG DER BIOAKTIVEN FRAKTION AUS DEM URINDESTILLAT DER KUH (ßGO MUTRAß) ZUR VERSTÄRKUNG DER WIRKSAMKEIT VON ANTI-INFEKTIVA, ANTI-KREBSMITTELN UND ERNÄHRUNGSMITTELN ATE273014T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2000/000106 WO2002032436A1 (en) 2000-10-20 2000-10-20 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients

Publications (1)

Publication Number Publication Date
ATE273014T1 true ATE273014T1 (de) 2004-08-15

Family

ID=11076279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00990873T ATE273014T1 (de) 2000-10-20 2000-10-20 VERWENDUNG DER BIOAKTIVEN FRAKTION AUS DEM URINDESTILLAT DER KUH (ßGO MUTRAß) ZUR VERSTÄRKUNG DER WIRKSAMKEIT VON ANTI-INFEKTIVA, ANTI-KREBSMITTELN UND ERNÄHRUNGSMITTELN

Country Status (11)

Country Link
EP (1) EP1330253B1 (de)
KR (1) KR100848394B1 (de)
CN (2) CN100536856C (de)
AT (1) ATE273014T1 (de)
AU (3) AU2001230486B2 (de)
BR (1) BR0017342A (de)
CA (1) CA2425025C (de)
DE (1) DE60012996T2 (de)
DK (1) DK1330253T3 (de)
MX (1) MXPA03002653A (de)
WO (1) WO2002032436A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087176A1 (en) * 2003-03-31 2004-10-14 Council Of Scientific And Industrial Research A composition (rucd) for protecting and/or repairing dna from oxidative damages and a method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248295A (en) * 1962-12-26 1966-04-26 Canadian Patents Dev Anti-allergic urine extract and method of making same
KR100523463B1 (ko) * 2003-05-30 2005-10-25 영남대학교 산학협력단 노루오줌 추출물 또는 이로부터 분리된 아스틸빅산 및펠토보이키놀릭산 유도체를 함유하는 항염증 또는항알러지 조성물

Also Published As

Publication number Publication date
AU2005237162B2 (en) 2007-02-08
DK1330253T3 (da) 2004-10-04
MXPA03002653A (es) 2004-01-29
CA2425025C (en) 2010-11-23
EP1330253A1 (de) 2003-07-30
CN1788735A (zh) 2006-06-21
BR0017342A (pt) 2004-02-03
WO2002032436A1 (en) 2002-04-25
DE60012996T2 (de) 2005-01-27
CN1454092A (zh) 2003-11-05
CN1234372C (zh) 2006-01-04
KR100848394B1 (ko) 2008-07-24
EP1330253B1 (de) 2004-08-11
CA2425025A1 (en) 2002-04-25
CN100536856C (zh) 2009-09-09
AU3048601A (en) 2002-04-29
DE60012996D1 (de) 2004-09-16
AU2001230486B2 (en) 2005-11-10
KR20040015010A (ko) 2004-02-18
AU2005237162A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
CA2359510A1 (en) .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1140840A4 (de) -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren
HK1155944A1 (en) W-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
ATE362766T1 (de) Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
BR9405798A (pt) Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
TR200201094T2 (tr) Farmasötik maddeler olarak bisiklik amino asitler
ATE377592T1 (de) Neurotropische substituierte pyrimidine
EP3081214A3 (de) Zellnekrosehemmer
BR9914360A (pt) N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5
UY26130A1 (es) Compuestos para tratar la obesidad
ATE223399T1 (de) Quinazolin-4-on ampa antagonisten
EP1736470A3 (de) Pyrimidin-Derivate als cb2 Cannabinoid-Rezeptor Modulatoren
ATE317846T1 (de) Phosphoramidat-prodrugs
EE200100125A (et) TAN-1057 derivaadid
BR9803385A (pt) AtropisÈmeros de 2,3-dissubstituìdo-(5,6)-heteroaril condensado-pirimidin-4-onas.
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
ATE273014T1 (de) VERWENDUNG DER BIOAKTIVEN FRAKTION AUS DEM URINDESTILLAT DER KUH (ßGO MUTRAß) ZUR VERSTÄRKUNG DER WIRKSAMKEIT VON ANTI-INFEKTIVA, ANTI-KREBSMITTELN UND ERNÄHRUNGSMITTELN
MY138502A (en) Novel alkansulfonamides as endothelin antagonists
WO2003037335A8 (en) 5-heteroatom-substituted pyrazoles
BR0204430A (pt) 5-(alquilideno-cicloalquil)- e 5-(alquilideno-heterociclil)-pirazóis
ATE299704T1 (de) Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril
CO4940459A1 (es) Composicion para el tratamiento de trastornos gastrointesti- nales y metodo para su fabricacion
ATE382342T1 (de) Pomolsäure zur behandlung von mehrfachresistenten tumoren
BG105763A (en) Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ECSP003318A (es) UREAS DIFENIL -w -CARBOXIARIL SUBSTITUIDAS COMO INHIBIDORES DE RAF QUINASA

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties